Results with Optilume consistent in clinical trials and real world, regardless of prostate ...

The Urocross® Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is ...

One such change, often less spoken about, is the enlargement of the prostate gland. This condition, known as Benign Prostatic Hyperplasia (BPH), is extremely common, especially in men above 50 years ...

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...

What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch ...

Prodeon Medical’s Urocross Expander System receives US FDA 510(k) clearance for treating urinary symptoms associated with benign prostatic hyperplasia: Sunnyvale, California Thu ...

BECKLEY, WV (WVNS) — Dr. Lynetta Payne, a urologist at Raleigh General Hospital, has reached the milestone of 200 successful ...

By focusing on hydration, diet, physical activity, and routine screenings early in life, many conditions that may likely emerge later in life can be avoided altogether.

Image courtesy of Prodeon Medical] Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross ...

Dr G. Senthilvel, director of National Institute of Siddha, said that despite facing challenges in global acceptance, ...

A consultant urological surgeon has explained why you need to prepare before a cancer check ...